Kyoko Mori

Ribavirin suppresses hepatic lipogenesis through inosine monophosphate dehydrogenase inhibition: Involvement of adenosine monophosphate‐activated protein kinase‐related kinases and retinoid X receptor α

M. Honda, S. Kaneko, N. Kato, 2017, Hepatology communications.

Oncostatin M synergistically inhibits HCV RNA replication in combination with interferon‐α

N. Kato, M. Ikeda, Y. Ariumi, 2009, FEBS letters.

Anti-HCV activity of the Chinese medicinal fungus Cordyceps militaris.

N. Kato, M. Ikeda, K. Mori, 2014, Biochemical and biophysical research communications.

Identification of host genes showing differential expression profiles with cell-based long-term replication of hepatitis C virus RNA.

N. Kato, M. Ikeda, Y. Ariumi, 2012, Virus research.

Gene expression profile of Li23, a new human hepatoma cell line that enables robust hepatitis C virus replication: Comparison with HuH‐7 and other hepatic cell lines

N. Kato, M. Ikeda, Y. Ariumi, 2010 .

Ca2+/S100 proteins regulate HCV virus NS5A–FKBP8/FKBP38 interaction and HCV virus RNA replication

H. Tokumitsu, T. Masaki, N. Kato, 2013, Liver international : official journal of the International Association for the Study of the Liver.

Anti‐ulcer agent teprenone inhibits hepatitis C virus replication: potential treatment for hepatitis C

M. Yano, N. Kato, M. Ikeda, 2011, Liver international : official journal of the International Association for the Study of the Liver.

Adenosine kinase is a key determinant for the anti‐HCV activity of ribavirin

Y. Wataya, N. Kato, M. Ikeda, 2013, Hepatology.

Efficient replication systems for hepatitis C virus using a new human hepatoma cell line.

N. Kato, M. Ikeda, T. Wakita, 2009, Virus research.

A new living cell-based assay system for monitoring genome-length hepatitis C virus RNA replication.

N. Kato, M. Ikeda, Y. Ariumi, 2008, Virus research.